Caricamento...
Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma
Background: Although the introduction of protease inhibitor bortezomib (BTZ) and immunomodulatory agent lenalidomide has led to improved outcomes in patients with multiple myeloma (MM), the disease remains incurable. Gambogenic acid (GNA), a polyprenylated xanthone isolated from the traditional Chin...
Salvato in:
| Pubblicato in: | J Cancer |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Ivyspring International Publisher
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5381173/ https://ncbi.nlm.nih.gov/pubmed/28382147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17657 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|